JOHNSON & JOHNSON - 23 Aug 2023 Form 4 Insider Report for Kenvue Inc. (KVUE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Aug 2023, 16:53:18 UTC
Prior SEC filing
03 May 2023
Next SEC filing
06 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
JOHNSON & JOHNSON, /s/ Laura H. McFalls, Assistant Secretary

Key filing fact

JOHNSON & JOHNSON filed Form 4 for Kenvue Inc. (KVUE) on 25 Aug 2023.

Key facts

  • This page summarizes JOHNSON & JOHNSON's Form 4 filing for Kenvue Inc. (KVUE).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Aug 2023, 16:53.

Change

  • Previous filing in this sequence was filed on 03 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KVUE transaction

Common Stock

Other

Transaction value
Shares
-1,533,830,450
Change %
-89%
Price
Shares after
182,329,550
Date
23 Aug 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

JOHNSON & JOHNSON is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Johnson & Johnson disposed of 1,533,830,450 shares of Issuer common stock in exchange for 190,955,436 shares of Johnson & Johnson common stock pursuant to a registered exchange offer to holders of shares of Johnson & Johnson common stock. The final exchange ratio was 8.0324 shares of Issuer common stock per share of Johnson & Johnson common stock accepted in the exchange offer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .